隨著我國(guó)中醫(yī)藥事業(yè)的蓬勃發(fā)展,中藥在臨床上應(yīng)用亦越來(lái)越廣泛,但中藥的安全性問(wèn)題亦備受關(guān)注。需要進(jìn)行醫(yī)療機(jī)構(gòu)中藥制劑不良反應(yīng)監(jiān)測(cè)管理體系建設(shè),明確主要監(jiān)測(cè)范圍,把控相關(guān)環(huán)節(jié)風(fēng)險(xiǎn)和防范,進(jìn)行宣傳和培訓(xùn)。介紹了醫(yī)療機(jī)構(gòu)中藥制劑不良反應(yīng)監(jiān)測(cè)的管理內(nèi)容和對(duì)策,以期為各醫(yī)療機(jī)構(gòu)中藥制劑不良反應(yīng)監(jiān)測(cè)提供參考。

With the vigorous development of traditional Chinese medicine in China, the clinical application of traditional Chinese medicine is becoming increasingly widespread, but the safety issues of traditional Chinese medicine preparations are also of great concern. It is necessary to establish a monitoring and management system for adverse reactions of traditional Chinese medicine preparations in medical institutions, clarify the main monitoring scope, control relevant risks and prevention, and carry out publicity and training. This article introduces management and countermeasures of adverse reaction monitoring on traditional Chinese medicine preparations in medical institutions, in order to provide reference for monitoring adverse reactions of traditional Chinese medicine preparations in various medical institutions.

R954

國(guó)家自然科學(xué)基金資助項(xiàng)目(82274684);山東省中醫(yī)藥科技項(xiàng)目(Q-2022020);山東省藥品不良反應(yīng)監(jiān)測(cè)中心委托項(xiàng)目(2017SDADRKY04);濰坊市中醫(yī)藥科研計(jì)劃項(xiàng)目(WFZYY2022-4-020)